4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001378830-25-000003
CEO, President, and Secretary bought 200,000 shares at an average $0.68 ($135,575)
From the SEC's structured data for this filing
Trades in this filing
Patel Sujal M · CEO, President, and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-05 | Purchase : show line 1 in the form | +116,500 | $0.67 | $78,544 | 10,258,221 | D |
| 2025-09-08 | Purchase : show line 2 in the form | +83,500 | $0.68 | $57,031 | 10,341,721 | D |
| Open-market purchases · 200,000 sh · avg $0.68 · $135,575 | ||||||
Loading xslF345X05/wk-form4_1757450542.xml…